ENSG00000223804 and cancer: For new testing patients with other cancer types, RFC calculated the similarity between Group 1, “CESC-like” containing potential signal of increase in POLI expression worsening survival, and Group 2, “PAAD-like” containing potential signal of increase POLI expression improving survival.